Contribution of endogenous endothelin-1 to the maintenance of vascular tone: Role of nitric oxide

Pharmacology

Volumn 55, Issue 6, 1997, Pages 299-308

  Gellai, Miklos ^a   De Wolf, Robin ^a   Fletcher, Tracey ^a   Nambi, Ponnal ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Blood pressure; Endothelin 1 Nitric oxide; Renal blood flow; Sarafotoxin 6c L NNA; SB 209670 BQ123

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; N(G) NITROARGININE; NITRIC OXIDE; RECEPTOR SUBTYPE; RES 701 1; SARAFOTOXIN S6C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; CONTROLLED STUDY; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 0030728708     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139542     Document Type: Article

References (43)

1. Liischer TF, Bock HA. Yang Z, Diederich D: Endothelium-derived relaxing and contracting factors: Perspectives in nephrology. Kidney Int 1991;39:575-590.
2. Palmer RMJ, Ashton DS. Moncada S: Vascular endothelial cells synthesize nitric oxide from /.-arginine. Nature 1988;333:664-666.
3. Rees DD, Palmer RMJ, Ilodson HF, Moncada S: A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989:96:418-424.
4. Haynes WG. Noon JP. Walker BR. Webb DJ: Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993; 11:1375-1380.
5. M-nitro-/.-arginine methyl ester on renal function and blood pressure. Am.1 Physiol 1991: 261:F1033-F1037.
6. Tolins JP. Palmer RMJ, Moncada S. Raij L: Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physio! 1990;258:H655-H662.
7. Qui C. Engels K. Baylis C: Endothe-lin modulates the pressor actions of acute systemic nitric oxide blockade. J Am Soc Nephrol I995;6: 1476-1481.
8. Bowcn-Pope DF. Heart CE. Seifert RA: Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem 1989: 264:2502-2508.
9. Yanagisawa M. Kurihara H. Kimu-ra S, Tomobe Y. Kobayashi M. Mitsui Y. Yazaki Y, Goto K. Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988:332:411-415.
10. A receptor antagonist in the rat. J Clin Invest 1994:93:900-906.
11. Miyauchi T, Yanagisawa M, Tomi-zawa T, Sugishata Y. Suzuki N. Fu-jino M. Ajisaka R. Goto K. Masaki T: Increased plasma concentrations ofcndothelin-l and bigendothelin-1 in acute myocardial infarction. Lancet 1989:53-54.
12. Stewart DJ. Levy R. Cernacek P. Langleben D: Increased plasma cn-dothclin-l in pulmonary hypertension-marker or mediator of disease? Ann Intern Med 1991:114: 464-469.
13. Gellai M. De Wolf R. Pullen M. Nambi P: Distribution and functional role of renal ET receptor sub-types in normotensivc and hypertensive rats. Kidney Int 1994:46: 1287-1294.
14. Gardiner SM. March JE. Kemp PA. Mullins JJ, Bennett T: Haemodynamic effects of Iosartan and the endothclin antagonist, SB 209670. in conscious, transgenic ((mRen-2)27), hypertensive rats. Br.1 Pharmacol 1995:116:2237-2244.
15. Donckier J. Stoleru L. Hayashida W, Van Mechelen H. Selvais P. Galant i L, Clozel JP. Ketelslcgers JM. Pouleur H: Role of endogenous cn-dothelin-l in experimental renal hypertension in dogs. Circulation 1995;92:106-113.
16. Kato T. Kassab S. Wilkins FC Jr. Kirchner KA. Kciser J. Granger JP: Endothclin antagonists improve renal function in spontaneously hypertensive rats. Hypertension 1995; 25:883-887.
17. Tccrlink JR. Loftier BM. Hess P, Maire JP. Clozel M, Clozel JP: Role of endothclin in the maintenance of blood pressure in conscious rats with chronic heart failure: Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). Circulation 1994:90:2510-2518.
18. Arai H, Hori S. Aramori I. Ohkubo H. Nakanish S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990:348: 730-732.
19. Sakurai T, Yanagiswa M. Takuwa Y. Miyazaki H. Kimura S. Goto K. Masaki TE: Cloning of a cDNA encoding a nonisopeptidc-sdective subtype of an endothclin receptor. Nature 1990:348:732-735.
20. Gardiner SM. Kemp PA. March JE. Bennett T, Davenport AP, Edvins-son L: Effects of an ET 1-receptor antagonist, FR 139317, on regional haemodynamic responses to endothelin-1 and [Alai 1.15]Ac-endothc-lin-l (6-21) in conscious rats. Br J Pharmacol 1994;112:477-486.
21. Haynes WG: Endothelins as regulators of vascular tone in man. Clin Sci 1995:88:509-517.
22. Warner TD, Allcock GH. Corder R, Vane JR: Use of the endothclin antagonists BQI23 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 1993:110:777-782.
23. Teerlink JR, Carteaux JP. Sprecher U. Loffler BM, Clozel M. Clozel JP: Role of endogenous endothclin in normal hemodynamic status of anesthetized dogs. Am J Physiol I995;268:H432-H440.
24. Yamashita Y. Yukimura T, Miura K. Okumura M. Yamamoto K: Effects of endothelin-3 on renal functions. J Pharmacol Exp Ther 1991; 259:1256-1259.
25. Yukimura T. Yamashita Y, Miura K. Kim S. Iwao H, Takai M. Okada T: Renal vasodilating and diuretic actions of a selective endothelin ETb receptor agonist. IRL 1620. Eur J Pharmacol 1994:264:399-405.
26. Gellai M. Flctschcr T. Pullen M, Nambi P: Evidence for the existence of cndothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol 1996:271:R254-R26I.
27. Tanaka T. Tsukuda E, Nozawa M. Nonaka H. Ohno T, Kase H, Yamada K, Matsuda Y: RES-701-1. a novel potent endothelin type B receptor-selective antagonist of microbial origin. Mol Pharmacol 1994:45: 724-730.
28. Gellai M. Vallin H: Chronic vascular constrictions and measurements of renal function on conscious rats. Kidney Int 1979;15:419-426.
29. Haywood JR. Shaffer RA, Fastcnow C, Fink GD, Brody MJ: Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol 1981:241: H273-H278.
30. f'-mono-methyl-L-argininc in conscious rats. Br J Pharmacol 1996:118:352-354.
31. Richard V, Hogic M. Clozel M, Loffler BM, Thuillez C: In vivo evidence of an endothelin-induced vasopressor lone after inhibition of nitric oxide synthesis in rats. Circulation 1995;91:771-775.
32. Richard V. Hogie M. Clozel M. Loffler BM, Thuillez C: Demonstration of a vasopressor role of endogenous endothclin after inhibition of nitric oxide synthesis in rats (in French). Arch Mal Cœur Vaiss 1995;88:1213-1216.
33. Loesch A. Bumstock G: Ultrastructural localization of nitric oxide synthase and endothclin in coronary and pulmonary' arteries of newborn rats. Cell Tissue Res 1995:279:475-483.
34. Loesch A. Bumstock G: Ultrastructural localization of nitric oxide synthase and endothelin in rat pulmonary artery and vein during postnatal development and ageing. Cell Tissue Res 1996;283:355-365.
35. Ercan ZS. Turkcr RK, Uluoglu C. Yazar O, Zengil H: The effects of endothelin peptides in the rabbit isolated perfused kidney. Gen Pharmacol 1994:25:1471-1476.
36. Hirata Y. Hayakawa H. Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobc M. Omata M: Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Circulation 1995;91: 1229-1235.
37. Gupta S, McArthur C, Grady C, Ruderman NB: Role of endothelium-derived nitric oxide in stimulation of Na(+)-K(+)-ATPase activity by endothelin in rabbit aorta. Am J Physiol 1994;266:H577-H582.
38. Ran P, Xu J. Chen S: Expression of endothelin-1 mRNA. endothelin re-ceptor-A and nitric oxide synthase mRNA in pulmonary artery and right ventriculus cordis of rats exposed to hypoxia. Chung Hua I Hsuch Tsa Chih 1995;75:479-481.
39. Redmond EM. Cahill PA. Hodges R, Zhang S. Sitzmann JV: Regulation of endothelin receptors bynitric oxide in cultured rat vascular smooth muscle cells. J Cell Physiol 1996:166:469-479.
40. Kohan DE. Padilla E: Endothelin-1 production by rat inner medullary collecting duct: Effect of nitric oxide. cGMP, and immune cytokines. Am J Phvsiol 1994;266:F291-F297.
41. Kourcmbanas S, McQuillan LP. Leung GK, Faller DV: Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both nor-moxia and hypoxia. J Clin Invest 1993:92:99-104.
42. Lerman A, Sandok EK. Hildebrand FL Jr. Burnett JC Jr.: Inhibition of endothelium-derived relaxing factor enhances cndothelin-mcdiatcd vasoconstriction. Circulation 1992:85: 1894-1898.
43. Lofflcr B. Breu V. Clozcl M: EITcct of different endothelin receptor antagonists and of the novel non-pep-tide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett 1993:333:108-110